Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.

Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM.

Haematologica. 2013 Jun;98(6):908-12. doi: 10.3324/haematol.2012.076729. Epub 2013 Jan 24.


Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML.

Payne EM, Bolli N, Rhodes J, Abdel-Wahab OI, Levine R, Hedvat CV, Stone R, Khanna-Gupta A, Sun H, Kanki JP, Gazda HT, Beggs AH, Cotter FE, Look AT.

Blood. 2011 Jul 28;118(4):903-15. doi: 10.1182/blood-2010-11-318022. Epub 2011 Jun 7.


Warfarin-induced skin necrosis in a patient with heparin-induced thrombocytopenia: two diseases or one?

Abdel-Wahab OI, Rosovsky RP, Warth JA.

Acta Haematol. 2008;120(2):117-22. doi: 10.1159/000174756. Epub 2008 Nov 19.


Primary myelofibrosis: update on definition, pathogenesis, and treatment.

Abdel-Wahab OI, Levine RL.

Annu Rev Med. 2009;60:233-45. doi: 10.1146/ Review.


Functional evaluation of the grafted wall with porcine-derived small intestinal submucosa (SIS) to a stomach defect in rats.

Ueno T, de la Fuente SG, Abdel-Wahab OI, Takahashi T, Gottfried M, Harris MB, Tatewaki M, Uemura K, Lawson DC, Mantyh CR, Pappas TN.

Surgery. 2007 Sep;142(3):376-83.


Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine.

Ueno T, Ko SH, Grubbs E, Yoshimoto Y, Augustine C, Abdel-Wahab Z, Cheng TY, Abdel-Wahab OI, Pruitt SK, Friedman HS, Tyler DS.

Mol Cancer Ther. 2006 Mar;5(3):732-8.


Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity.

Ko SH, Ueno T, Yoshimoto Y, Yoo JS, Abdel-Wahab OI, Abdel-Wahab Z, Chu E, Pruitt SK, Friedman HS, Dewhirst MW, Tyler DS.

Clin Cancer Res. 2006 Jan 1;12(1):289-97.


The role of hyperthermia in regional alkylating agent chemotherapy.

Abdel-Wahab OI, Grubbs E, Viglianti BL, Cheng TY, Ueno T, Ko S, Rabbani Z, Curtis S, Pruitt SK, Dewhirst MW, Tyler DS.

Clin Cancer Res. 2004 Sep 1;10(17):5919-29.


Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution.

Abdel-Wahab Z, Kalady MF, Emani S, Onaitis MW, Abdel-Wahab OI, Cisco R, Wheless L, Cheng TY, Tyler DS, Pruitt SK.

Cell Immunol. 2003 Aug;224(2):86-97.


Supplemental Content

Loading ...
Support Center